-
90%
Acute Lymphoblastic Leukemia ( ...
E2A-PBX1; TEL-AML1; MLL-AF4; MLL-ENL; MLL-AF9; BCR-ABL1 (Major,Minor/Micro)Acute Lymphoblastic Leukemia ( ...
E2A-PBX1; TEL-AML1; MLL-AF4; MLL-ENL; MLL-AF9; BCR-ABL1 (Major,Minor/Micro) -
137%
AML Panel by PCR
PML RARA; AML ETO; CBFB-MYH11; BCR-ABL1 (Major, Minor); C-KIT; NMP1; FLT3-ITD; FLT3-TKDAML Panel by PCR
PML RARA; AML ETO; CBFB-MYH11; BCR-ABL1 (Major, Minor); C-KIT; NMP1; FLT3-ITD; FLT3-TKD -
205%
BCR-ABL Qualitative By PCR
CML marker -
205%
BCR-ABL Quantitative by PCR
To help diagnose and monitor the treatment of chronic myelogenous leukemia (CML) and a type of…BCR-ABL Quantitative by PCR
To help diagnose and monitor the treatment of chronic myelogenous leukemia (CML) and a type of… -
206%
Beta Thalassemia 16 mutation D ...
Beta Thalassemia gene Mutation -
222%
BRAF Mutation Analysis
Melanoma, Papillary Thyroid , Colorectal and NSCLC-FFPE, Hairy Cell leukemia (Blood)BRAF Mutation Analysis
Melanoma, Papillary Thyroid , Colorectal and NSCLC-FFPE, Hairy Cell leukemia (Blood) -
225%
C- Kit Mutation Analysis
CKIT (EXONS 9,11,13,14,17) - 234%
-
236%
CHIMERISM – KMR GENOTYPI ...
Chimerism analysis after allogeneic bone marrow transplantation (alloBMT) allows detection of early marrow engraftment, disease relapse,…CHIMERISM – KMR GENOTYPI ...
Chimerism analysis after allogeneic bone marrow transplantation (alloBMT) allows detection of early marrow engraftment, disease relapse,…
